(Q41540829)

2 October 2017

title

Symptom patterns in unipolar and bipolar depression correlating with monoamine metabolites in the cerebrospinal fluid: I. General patterns (English)

1 reference

2 October 2017

0 references

1 reference

H. Agren

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6171840

20 August 2023

language of work or name

English

0 references

publication date

1 October 1980

1 reference

full work available at URL

2 October 2017

https://api.elsevier.com/content/article/PII:0165178180900384?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90038-4

https://api.elsevier.com/content/article/PII:0165178180900384?httpAccept=text/plain

20 August 2023

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90038-4

20 August 2023

1 reference

2 October 2017

volume

3

1 reference

2 October 2017

issue

2

1 reference

2 October 2017

page(s)

211-223

1 reference

Monoamine metabolites in cerebrospinal fluid and serotonin uptake inhibition during treatment with chlorimipramine

2 October 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90038-4

5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor?

20 August 2023

2

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90038-4

Tricyclic antidepressants: long-term treatment increases responsivity of rat forebrain neurons to serotonin

20 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90038-4

Use of the Research Diagnostic Criteria and the Schedule for Affective Disorders and Schizophrenia to study affective disorders

20 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90038-4

Studies of amine metabolites in affective illness and in schizophrenia: a comparative analysis

20 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90038-4

Interactions of pharmacological agents which alter biogenic amine metabolism and depression--an analysis of contributing factors within a primate model of depression

20 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90038-4

3-Methoxy-4-hydroxy phenylglycol (MHPG) excretion in depressive states. A pilot study.

20 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90038-4

Brain biogenic amine depletion and mood

20 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90038-4

Depression vulnerability and 5-hydroxytryptophan prophylaxis

20 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90038-4

Norepinephrine metabolites as biochemical criteria for classifying depressive disorders and predicting responses to treatment: preliminary findings.

20 August 2023

15

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90038-4

Relationships in Healthy Volunteers Between Concentrations of Monoamine Metabolites in Cerebrospinal Fluid and Family History of Psychiatric Morbidity

20 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90038-4

Biogenic amine metabolites in cerebrospinal fluid of patients with affective disorders

20 August 2023

17

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90038-4

Correlations between height of subject and concentrations of monoamine metabolites in cerebrospinal fluid from psychotic men and women

20 August 2023

19

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90038-4

Novel Antidepressants and the Biogenic Amine Hypothesis of Depression

20 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90038-4

20 August 2023

Identifiers

1 reference

2 October 2017

1 reference